Quick Answer
NEUROCRINE BIOSCIENCES INC reported Shares Outstanding of 100.10 million shares for fiscal year 2025.
NEUROCRINE BIOSCIENCES INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 100.10M | +0.7% |
| 2024 | 99.40M | +0.7% |
| 2023 | 98.70M | +2.3% |
| 2022 | 96.50M | +1.7% |
| 2021 | 94.90M | +1.5% |
| 2020 | 93.50M | +1.3% |
| 2019 | 92.30M | +1.7% |
| 2018 | 90.80M | +2.3% |
| 2017 | 88.79M | +2.2% |
| 2016 | 86.88M | +0.7% |
| 2015 | 86.26M | +12.8% |
| 2014 | 76.47M | +13.5% |
| 2013 | 67.35M | +1.4% |
| 2012 | 66.45M | +20.2% |
| 2011 | 55.26M | +0.7% |
| 2010 | 54.88M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 99.70M | -1.5% | +0.7% |
| June 30, 2025 | 99.00M | -1.9% | +0.0% |
| March 31, 2025 | 99.00M | -1.6% | -0.4% |
| December 31, 2024 | 99.40M | +0.7% | -1.8% |
| September 30, 2024 | 101.20M | +3.1% | +0.3% |
| June 30, 2024 | 100.90M | +3.4% | +0.3% |
| March 31, 2024 | 100.60M | +3.2% | +1.9% |
| December 31, 2023 | 98.70M | +2.3% | +0.5% |
- NEUROCRINE BIOSCIENCES INC showed an increase of +0.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, NEUROCRINE BIOSCIENCES INC’s shares outstanding has grown by 82.4% (from 54.88 million shares to 100.10 million shares).
- The most recent figure is from NEUROCRINE BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: